Since inflammation is the one of key features in neurodegenerative diseases, it is necessary to investigate the anti-inflammatory effect of NSCs expressing IDO in other neurodegenerative animal models such as stroke, AD, or PD to further broaden their therapeutic potential. Here, IDO1 is linked to Parkinson disease.